Cargando…
Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia
X-linked agammaglobulinemia (XLA) is a primary immunodeficiency of the humoral compartment, due to a mutation in the Bruton tyrosine kinase (BTK) gene, characterized by a severe defect of circulating B cells and serum immunoglobulins. Recurrent infections are the main clinical manifestations; althou...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686078/ https://www.ncbi.nlm.nih.gov/pubmed/23862092 http://dx.doi.org/10.1155/2013/735108 |
_version_ | 1782273753657376768 |
---|---|
author | Ariganello, Paola Angelino, Giulia Scarselli, Alessia Salfa, Irene Della Corte, Martina De Matteis, Arianna D'Argenio, Patrizia Livadiotti, Susanna Manno, Emma C. Russo, Cristina Finocchi, Andrea Cancrini, Caterina |
author_facet | Ariganello, Paola Angelino, Giulia Scarselli, Alessia Salfa, Irene Della Corte, Martina De Matteis, Arianna D'Argenio, Patrizia Livadiotti, Susanna Manno, Emma C. Russo, Cristina Finocchi, Andrea Cancrini, Caterina |
author_sort | Ariganello, Paola |
collection | PubMed |
description | X-linked agammaglobulinemia (XLA) is a primary immunodeficiency of the humoral compartment, due to a mutation in the Bruton tyrosine kinase (BTK) gene, characterized by a severe defect of circulating B cells and serum immunoglobulins. Recurrent infections are the main clinical manifestations; although they are especially due to encapsulated bacteria, a specific association with Campylobacter species has been reported. Here, we report the case of a boy with XLA who presented with relapsing Campylobacter jejuni systemic infections. His clinical history supports the hypothesis of the persistence of C. jejuni in his intestinal tract. Indeed, as previously reported, XLA patients may become chronic intestinal carriers of Campylobacter, even in absence of symptoms, with an increased risk of relapsing bacteraemia. The humoral defect is considered to be crucial for this phenomenon, as well as the difficulties to eradicate the pathogen with an appropriate antibiotic therapy; drug resistance is raising in Campylobacter species, and the appropriate duration of treatment has not been established. C. jejuni should always be suspected in XLA patients with signs and symptoms of systemic infection, and treatment should be based on antibiogram to assure the eradication of the pathogen. |
format | Online Article Text |
id | pubmed-3686078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-36860782013-07-16 Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia Ariganello, Paola Angelino, Giulia Scarselli, Alessia Salfa, Irene Della Corte, Martina De Matteis, Arianna D'Argenio, Patrizia Livadiotti, Susanna Manno, Emma C. Russo, Cristina Finocchi, Andrea Cancrini, Caterina Case Rep Pediatr Case Report X-linked agammaglobulinemia (XLA) is a primary immunodeficiency of the humoral compartment, due to a mutation in the Bruton tyrosine kinase (BTK) gene, characterized by a severe defect of circulating B cells and serum immunoglobulins. Recurrent infections are the main clinical manifestations; although they are especially due to encapsulated bacteria, a specific association with Campylobacter species has been reported. Here, we report the case of a boy with XLA who presented with relapsing Campylobacter jejuni systemic infections. His clinical history supports the hypothesis of the persistence of C. jejuni in his intestinal tract. Indeed, as previously reported, XLA patients may become chronic intestinal carriers of Campylobacter, even in absence of symptoms, with an increased risk of relapsing bacteraemia. The humoral defect is considered to be crucial for this phenomenon, as well as the difficulties to eradicate the pathogen with an appropriate antibiotic therapy; drug resistance is raising in Campylobacter species, and the appropriate duration of treatment has not been established. C. jejuni should always be suspected in XLA patients with signs and symptoms of systemic infection, and treatment should be based on antibiogram to assure the eradication of the pathogen. Hindawi Publishing Corporation 2013 2013-06-03 /pmc/articles/PMC3686078/ /pubmed/23862092 http://dx.doi.org/10.1155/2013/735108 Text en Copyright © 2013 Paola Ariganello et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Ariganello, Paola Angelino, Giulia Scarselli, Alessia Salfa, Irene Della Corte, Martina De Matteis, Arianna D'Argenio, Patrizia Livadiotti, Susanna Manno, Emma C. Russo, Cristina Finocchi, Andrea Cancrini, Caterina Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia |
title | Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia |
title_full | Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia |
title_fullStr | Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia |
title_full_unstemmed | Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia |
title_short | Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia |
title_sort | relapsing campylobacter jejuni systemic infections in a child with x-linked agammaglobulinemia |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686078/ https://www.ncbi.nlm.nih.gov/pubmed/23862092 http://dx.doi.org/10.1155/2013/735108 |
work_keys_str_mv | AT ariganellopaola relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia AT angelinogiulia relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia AT scarsellialessia relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia AT salfairene relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia AT dellacortemartina relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia AT dematteisarianna relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia AT dargeniopatrizia relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia AT livadiottisusanna relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia AT mannoemmac relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia AT russocristina relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia AT finocchiandrea relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia AT cancrinicaterina relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia |